Lifecore Biomedical
LFCR
LFCR
90 hedge funds and large institutions have $367M invested in Lifecore Biomedical in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 38 increasing their positions, 19 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
2% less funds holding
Funds holding: 92 → 90 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $14K
Holders
90
Holding in Top 10
1
Calls
–
Puts
$14K
Top Buyers
| 1 | +$2.67M | |
| 2 | +$1.77M | |
| 3 | +$1.72M | |
| 4 |
Renaissance Technologies
New York
|
+$1.25M |
| 5 |
AI
Acuitas Investments
Seattle,
Washington
|
+$919K |
Top Sellers
| 1 | -$4.81M | |
| 2 | -$4.63M | |
| 3 | -$2.55M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.69M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$1.19M |